Abstract. Early development of the urodele amphibian Pleurodeles waltl is accompanied by a process of progressive fibronectin (FN) fibrillogenesis. FN begins to assemble into fibrils on the inner surface of the blastocoele roof at the early blastula stage and progressively forms a complex extracellular matrix. We have analyzed the mechanisms of FN-fibril formation under normal and experimental conditions in vivo with the following probes: iodinated FN, fluoresceinlabeled FN, synthetic peptides containing the Arg-GlyAsp (RGD) cell surface recognition sequence of FN, and polyclonal antibodies against both/3~ subunit of the amphibian FN receptor and the cytoplasmic domain of/3~ subunit. We report that in living embryos, exogenous labeled mammalian FN injected into the amphibian blastocoele undergoes FN-fibril formation in spatiotemporal patterns similar to those of endogenous FN. This indicates regulation of fibrillogenesis by the cell surface rather than by changes in the type of FN. Fibrillogenesis is inhibited in a dose-dependent manner both by the GRGDS peptide and monospecific antibodies to amphibian integrin/3~ subunit. Furthermore, when injected intracellularly into uncleaved embryos or into selected blastomeres, antibodies to the cytoplasmic domain of integrin/~t subunit produce a reversible inhibition of FN-fibril formation that follows early cell lineages and cause delays in development. Together, these data indicate that in vivo, the integrin /3t subunit and the RGD recognition signal are essential for the proper assembly of FN fibrils in early amphibian development.
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T hE regulation of extracellular matrix assembly and cellular responses to these matrices are important for the control of morphogenesis and organogenesis. For instance, cell morphology, cell attachment and migration, tissue stability, cell polarity, and differentiation often require adhesion and specific interactions of a cell with its substratum. These interactions involve specific cell surface proteins that bind adhesive ligands of the extracellular matrix. A family of proteins that appears to provide such functions is known as the integrin superfamily (Hynes, 1987) . Protein and cDNA sequencing of these receptors as well as immunological analysis have established the existence of two multigene families of glycoproteins detected throughout the animal kingdom corresponding to integrin ot or # subunits (Tamkun et al., 1986; Argraves et al., 1987; Suzuki et al., 1987; DeSimone and Hynes, 1988; Marcantonio and Hynes, 1988; Cheresh et al., 1989) . These families are divided into distinct subfamilies, in which members share a common/3 subunit that is noncovalently combined with a unique ot subunit to form or//3 heterodimers. The ~ subunit appears to confer ligand-binding specificity. To date, three major subfamilies have been described: the leukocyte adhesion proteins (Leu-CAM) (Anderson and Springer, 1987) , cytoadhesins (Ginsberg et al., 1988) , and the very late antigens (VLAs) t . The integrin VLA family consists of heterodimers of six different ot subunits each associated with a common/3~ chain. The VLA-5 molecule (t~sB~) is directly implicated via its extracellular domain in the recognition of fibronectin (FN) (Pytela et al., 1985; Wayner et al., 1988; Akiyama et al., 1989a) . However, several other integrins also bind fibronectin, including c~3/3t, ~llb~3, and ~v/3x. The relationship between these FN adhesion receptors and FN matrix assembly remains uncertain at present (reviewed in McDonald, 1988 and Akiyama et al., 1989b) .
At the molecular level, FN matrix assembly could be modulated by at least three events (McDonald, 1988; Ruoslahti, 1988) : the binding of FN to one or more cell surface receptors, FN-FN binding, and finally FN-FN cross-linking and fibril elongation through both disulfide bond formation and the action of a transglutaminase (McKeown-Longo and Mosher, 1984; Homandberg and Erickson, 1986) . For the first event, two cell surface receptors have been proposed: the FN cell adhesion receptor (an integrin) and a "matrix assembly receptor." Previous studies suggest that the RGDcontaining cell adhesive domain and its integrin receptor may cooperate in FN-fibril assembly. For example, oncogenic transformation produces a loss of FN matrix and a diffuse distribution of FN receptors; on FN substrata, cells exhibit extracellular FN fibrils that colocalize with the FNreceptor complex Damsky et al., 1985) ; RGD-containing peptides that induce detachment of fibroblasts from extracellular FN matrix lead to diffuse receptor localization (Chen et al., 1986) ; and particularly importantly, cell adhesive fragments, anti-FN and anti-otsB~ antibodies that inhibit the binding of FN to its receptor, block FN-fibril formation by cultured fibroblasts (McDonald et al., 1987; Akiyama et al., 1989a; Roman et al., 1989) .
On the other hand, evidence for the matrix assembly receptor identified by McKeown-Longo and Mosher (1983) appears equally compelling, although its molecular composition remains unclear. This postulated matrix assembly system appears to be primarily dependent on the amino-terminal domain of FN, a region that has little or no cell adhesive activity (McKeown-Longo and Mosher, 1983 , 1985 Peters and Mosher, 1987; McDonald, 1988) . Furthermore, heparan sulfate proteoglycan may also be implicated in matrix deposition and attachment of fibroblasts (Woods et al., 1986) . A transmembrane heparan sulfate proteoglycan that binds to FN has been isolated (Rapraeger et al., 1986) . Finally, a severely ganglioside-deficient cell line does not assemble FN into a matrix, and matrix assembly is restored by certain exogenous gangliosides, implicating gangliosides in this process as well (Spiegel et al., 1985; 1986) .
In early amphibian development, an extracellular matrix containing FN fibrils undergoes assembly at the basal surface of cells that form the blastocoele roof (Boucaut and Darrib~re, 1983; Darrib~re et al., 1984 Darrib~re et al., , 1985 Johnson, 1981 Johnson, , 1985 Johnson et al., 1990; Lee et al., 1984; Nakatsuji et al., 1982 Nakatsuji et al., , 1985 . During gastrulation, these FN fibrils provide a substrate for mesodermal cell migration (Boucaut et al., 1984a,b; Nakatsuji and Johnson, 1984a,b) . Furthermore, immunological inhibition studies performed in vitro and in vivo, demonstrate that a complex of glycoproteins of 90-140 kD is involved in the binding of mesodermal cells to FN fibrils (Darrib~re et al., 1988) .
An important and still unanswered question concerns the actual mechanism of cell interactions with FN to form fibrils, as well as its regulation. We focused on the possibility that the/~ subunit found in the integrin VLA-5 may mediate or modulate these interactions. We initiated experiments to analyze the matrix assembly activity of blastomeres in living amphibian embryos. We have used RGD-containing peptides and both antibodies to the whole molecule or the cytoplasmic domain of the integrin ~ subunit to perturb its function. Our major findings are that exogenous FN incorporation into chimeric matrices is regulated in parallel with endogenous fibrillogenesis, and that RGD-containing peptides, polyclonal Fab' fragments of IgG to both the amphibian integrin /~ subunit (extracellularly), and the cytoplasmic domain of 8, (intracellularly) cause specific in vivo inhibition of the ability to incorporate labeled exogenous FN into extracellular matrices and to elaborate endogenous FN fibrils.
Materials and Methods

Embryos
Embryos of the urodele amphibian Pleurodeles wald Michah were collected from natural matings. They were manually dejellied and maintained at 18°C in 10% modified Barth solution (MBS) (Barth and Barth, 1959) containing 50 ~g/ml gentamycin (Gibco Laboratories, Grand Island, NY). Developmental stages of embryos were according to Gallien and Durocher (1957) .
Purification of Fibronectin
FN was prepared from fresh-frozen bovine plasma by gelatin-Scpharose affinity chromatography (Engvall and Ruoslahti, 1977) . Purity of FN was assessed by SDS-PAGE. If needed, FN was further purified using two cycles of gelatin-Sepharose chromatography.
Labeling of Fibronectin
Purified bovine plasma FN was labeled with lesI or FITC. The iodination of FN was carried out with Bolton and Hunter (1973) reagent (74 TBq/ mmoi; Amersham Corp., Arlington Heights, IL). By SDS-PAGE, the iodinated material migrated as a doublet at an apparent molecular mass of 220 kD under reducing conditions. For FITC labeling, FN in a 0.1 M sodium carbonate/bicarbonate buffer (pH 9) was incubated with FITC (200/~g/mg of FN; Sigma Chemical Co.; St. Louis, MO) for 2 h at room temperature and with gentle stirring (Che.rnousov et al., 1985) . Unreacted dye was removed by gel fltration on Sephadex G-50 eluted with MBS. For control experiments, BSA (fraction V; Sigma Chemical Co.) was labeled identically. Iodinated and fluorcscein-conjugated FNs retained their biological activity in cell spreading.assays described previously (Darrib6re et ai., 1988) .
Purification of lntegrin ~1 Subunits
Batches of 1,000 larvae (stage 39) of Pleurodeles waltl were homogenized in a Polytron (12,000 rpm, 1 rain, 4°C; Bioblock Scientific, France) in 40 mM octyl-/~-glucopyranoside (OGP; Calbiochem-Behring Corp., San Diego, CA), 2 mM PMSF, 2 mM EGTA, 5 tzg/ml aprotinin, 0.5/tg/ml leupeptin, 50 mM Tris-HCI pH 7.4 (buffer 2). Detergent extraction of proteins was carried out for 2 h at 4°C with stirring. Detergent-insoluble material was removed by centrifugation at 12,000 g for 15 min at 4°C. The resulting supernatant solution was incubated with Sepbarose 4B beads (10 ml of packed beads; Pharmacia Fine Chemicals, Piscataway, NJ) for 1 h at 4oc in order to remove proteins that bind nonspecifically to Sepharose 4B. After sedimentation, the supernatant solution was mixed overnight at 4°C by endover-end rotation with 10 ml packed volume of concanavalin A-Sepharose 4B (Sigma Chemical Co.). Bound proteins were eluted with 0.25 M t~-methyl-D-mannoside (Sigma Chemical Co.) in buffer. Fractions that react by immunoblotting with anti-avian integrin IgG were pooled and dialyzed against buffer 2 at 4°C. They were then incubated with the IgG .fractions of polyclonal antibodies against avian integrin VLA-5 coupled to CNBractivated Sepharose 41] (Pharmacia Fine Chemicals) at a ratio of 5 mg antibodies per l ml of packed beads according to Hasegawa et al. (1985) .
Antibodies and Peptides
Antibodies against the integrin/31 subunit of Pleurodeles waltl (anti-/J0 were raised in New Zealand white rabbits. Subcutaneous injections using 0.2 nag of amphibian integrin ~j emulsified 1:1 with Freund's complete or incomplete adjuvant were administered at 1-wk intervals. Rabbits were bled from an artery and IgG were purified from sera by chromatography on DEAE TrisacryI-M as recommended by the manufacturer (Indnstrie Biologic Franeaise, France). Polyclonal antibodies against the cytoplasmic domain of integrin/~l subunit (anti-/31 COOH) were produced by immunization of a rabbit with a synthetic peptide with the sequence CKLLMIIHDR-REFAKFEKEKM NAKW DTGEN PIYKSAVTTV VNPKYEGK (DcShnone and . The peptid¢ was conjugated to keyhole limpet haemocyanin (Pierce Chemical Co., Rockford, IL) with the heterobifunctional reagent m-maleimidobenzoic acid-N-hydroxysuccinimide ester (MBS; Pierce Chemical Co.) essentially as described (Walker et al., 1985) . This antibody immunoprecipitated the same human fibroblast intngrins as an existing antiEl monoclonal antibody (Akiyama et al., 1989a) , and showed the same immunoiocalization pattern; it also stained/~t and pre~t subunits as ex- (anti-FN) has been previously described (Boucaut and Darrib~re, 1983) . The specificity of IgG fractions was evaluated by immunopreeipitation and SDS-PAGE using [~$lmethionine-labeled whole embryo homogcnates ( Fig.  1) . Furthermore, anti-#~ lgG inhibit mesc~rmal cell attachment and spreading on FN-coated substrata. Monovalent fragments of these antibodies (Fab') were prepared according to Brackenbury et at. (1977) . Their purity was tested by SDS-PAGE. For control experiments we used nonimmnne Fab', or we attempted to block the activity of Fab' fragments with antigen. In the later case, anti-~ FalY or anti-/~s COOH FaN were mixed with purified amphibian integrin/31 subunit at a weight ratio of 1:1 in sterile 10% MBS. Both control probes were used immediately after low speed centrifugation (1,000 g, 10 min) to sediment insoluble material. Control blastomere injections were also performed with IgG fractions from rabbit, mouse, and human sera.
The synthetic peptides used were Gly-Arg-Gly-Asp-Ser (GRGDS), and Cys-GIn-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr (P2). They correspond to conserved and hydrophilic sequences from, the celt-binding and collagenbinding sites of FN, respectively (Yan~da and Kennedy, 1984; Pierschbather and Ruoslahti, 1984) .
Metabolic Labeling, lmmunoprecipitation, and Electrophoresis
Embryos at midgastrula stage (stage 10) were injected with 5 nl of [35S]methionine (555 MBq/ml; Amersham Corp.) and allowed to develop in 10% MBS for 4-6 h. They were then homogenized in buffer 3:0.1 M NaC1, I taM MAC12, 40 mM OGP, 2 mM PMSE 5 t~g/rnl aprotinin, 0.5 ttg/ml leupeptin, 50 mM Tris-HCl, pH 7.4, and extracted for 15 min at 4"C. Yolk and insoluble materials were removed at 10,0{30 g for 30 rain at 4°C. lmmunoprecipitations of FN, or of integrin/3, subunit were performed with protein A-Sepbarose CL-4B (Pharmacia Fine Chemicals). Nonspecific binding sites on beads were quenched by preincubating the beads with unlabeled extracts of embryonic proteins for I h at room temperature. Then, 5 mg of beads were incubated with 30 p.g of the appropriate lgG in 1 ml of butler 3 for 1 h at room temperature with stirring. After two washes with buffer 3, the beads were incubated with 1 ml of radioactive protein extract from 10 embryos overnight at 4"C with gentle stirring. After 10 washes with buffer 3, immunoprecipitates were analyzed by SDS-PAGE (Darrib~re et al., 1988) . Gels were stained with Coomassie blue, processed for fluorography using Amplify (Amersham Corp.), dried, and exposed with an intensifying screen (Dupont Lightning Plus, France) using Kodak XAR t~tm.
Injections
Embryos with diameter from 1.2 to 1.4 mm were collected when they reached the uncleaved, 2-cell, early, mid-, or late blastula stage (stages 0, 1, 5, 6, 7) and injected into blastomeres or the balstocoele. Iodinated FN, FITC-FN, or FITC-BSA were injected into early blastula blastocoeles (stage 5) in the absence or presence of peptides, anti-/3~ Fab', or preimmune antibodies. For injections, 200 nl of the blastocoele fluid was removed to prevent any overpressure during injection. Thereafter, 200 nl of a 0.05-1 mg/ml solution of reagents dissolved in 10% sterile MBS were injected (final amount per embryo: 10-200 rig). After injections embryos were incubated for 2, 4, 6, and 18 h in 10% MBS at 18"C. At each time, embryos were dissected in sterile MBS into animal (blastocoele roof, AP) and vegetal halves (VP). After careful washes, labeled FN binding was examined in both halves by immune precipitation, counting radioactivity, or direct fluorescence.
Anti-/3m COOH Fab' were introduced into nncleaved embryos (stage 0) or one blastomere of two-cell embryos (stage 1). Injections into uncleaved embryos were performed in the equatorial region and at least 3 h after fertilization. Uncleared embryos were injected with 10-50 nl (i.e., roughly 1/20-1/100 of the egg volume) of 0.05-10 mg/ml solutions of antibodies dissolved in 10% sterile MBS (final amount: 0.5-500 rig/embryo). Injections into biastomeres were performed with a volume of 5-30 rd (i.e., roughly 1/50-1/100 of the blastomere volume) of the same antibody solutions (final amount: 0.25-300 ng/blastomere) except that they also contained 50 mg/ml of lysir~ted rhedamine dextran (RLDx) (Gimlieh and Cooke, 1983 ) to follow the fltte of OffSpring of the injected biastomvre. After injections, embryos were reared in 10% MBS at 18°C in the dark to minimize bleaching of the fluorescent dye. Embryos were dissected and fixed for whole-mount studies of FN-fibril formation.
Immunofluorescence and Scanning Electron Microscopy
For whole-mount observations, the roof of the blastocoele was dissected from 124 cells to late gastrulae (stage.s 4-13) after removal of the viteiline membrane. Then, the explants were treated for immunodetection of FN as described previously (Boucaut and Darrib~re, 1983) . Scanning electron microscopy was carried out according to Nakatsuji et al. (1982) .
Results
l~bronectin-fibril Formation
The time course and pattern of normal in vivo fibril formation was established by indirect immunofluorescence for FN. W h e n the blastocoele begins to form in the eight-cell embryos (stage 3), there is no fluorescence for F N on the inner surface of blastomeres at the animal pole. In morulae (stage 4), no FN fibrils were yet observed. However, nonfibrillar fluorescent labeling was detected either as a ring around blastomeres near cell-cell contacts or as minute speckles on the surface of each blastomere (Fig. 2 A) . The first FN fibrils were observed 2 h later in early blastulae (stage 5). They were located primarily at the edges of the smallest cell surfaces of the blastocoele roof (Fig. 2 B) . In midblastulae (stage 6), fibrils appeared all around the cell periphery. They also crossed adjacent cell boundaries (Fig. 2 C) . They were smaller than those occurring at first and arranged perpendicular to the plane of contact between blastomeres. Within a span of ,o6 h, fibrils elongated from these peripheral sites toward the central portion of cell surface over the nucleus. In late blastulae (stage 7), fluorescent staining for FN was now well developed over most of the cell (Fig. 2 D) . FN fibrils were still more abundant at the periphery of each cell. At this stage, two kinds of fibrils can be distinguished: the first were short and thin, and the second were longer and thicker. 24 h after fertilization, in early gastrulae (stage 8a), FN fibrils formed a complex anastomosing fibrillar matrix, which covered the entire inner surface of the blastocoele roof. During gastrulation, the extracellular meshwork o.f FN fibrils showed further increases in density (Fig. 2 E) .
Exogenous Fibronectin-Fibril Formation
We tested the hypothesis that the time course and pattern of FN assembly was independent of the FN molecules themselves using interspecies injections. Exogenous labeled FN was injected into the blastocoele of early blastula (stage 5), when few fibrils are present (Fig, 2 B) . The binding of FN was studied with iodinated FN to quantify binding and with FITC-FN to localize injected FN.
The t25I-FN binding was examined by immunoprecipitation and SDS-PAGE. Autoradiograms revealed that ~25I-FN was bound preferentially to the animal hemisphere. The polypeptides corresponding to FN were detected from 2 to 18 h after the injection in the animal half of embryos. The incorporation of FN increased in time-dependent fashion.
'~ 5~000 Conversely, virtually no incorporation of labeled-FN occurred in the vegetal half of embryos. As a control for specific binding of '25I-FN, embryos (stage 5) were injected with a mixture of labeled (50 #g/ml, 100,000 cpm) and unlabeled FNs (200 ftg/ml). No trace of FN could be detected on autoradiograms even after lengthy exposure of the gels (data not shown). Bound FN was also measured by counting the radioactivity in the two embryonic halves. As shown in Fig. 3 A, iodinated bovine plasma FN bound to the blastocoele roof. The binding was time dependent, In contrast, the binding of exogenous FN to the vegetal half occurred at substantially lower rates throughout the period of incubation. Addition of excess unlabeled FN (200 ttg/ml), dramatically reduced the binding of '25I-FN to the animal hemisphere (Fig. 3 A) .
To determine where exogenous FN bound to the animal half, FN was also monitored by fluorescein labeling. Experiments were done with different concentrations of FN ranging from 10 to 100 #g/ml. Optimal incorporation was observed with 50 ftg/ml. The results show that exogenous FN is transferred to the extracellular matrix with the same timing and pattern as endogenous FN. Fluorescent fibrils were absent in controls where FITC-FN were mixed with an excess of unlabeled FN (200/zg/ml) or where FITC-BSA was injected. When surfaces of endodermal cells facing the blastocoele were observed, no fibrils could be detected with FITC-FN even after 18 h of incubation. Furthermore, at late blastula stage (stage 7), when the extracellular matrix of the blastocoele roof was transferred onto slides (Shi et al., 1989 ) and incubated for 18 h with FITC-FN, no fluorescent fibrils were detected, suggesting that cellular processes mediate fibrillogenesis (data not shown),
Inhibition of Fibronectin-fibril Formation by GRGDS and Anti-integrin [3l Subunit Antibodies Applied Extracellularly
Iodinated or fluoresceinated FN was injected into the blastocoele of early blastula (stage 5) in presence of either GRGDS or monovalent antibodies against integrin/~ subunit. The binding of FN was assessed by immune precipitation, counting of radioactivity, and immunofluorescence.
Immunoprecipitation followed by SDS-PAGE and autoradiography demonstrated that GRGDS, as well as anti-/~, Fab', inhibited the binding of FN to the roof of the blastocoele. Indeed, no trace of radioactive FN could be detected in presence of GRGDS or anti-/~, FalY even after an 18-h incubation. In contrast, polypeptides corresponding to FN were revealed after incubations with the collagen binding site of FN (peptide P2).
Quantitative radioactivity binding data were obtained for blastocoele roof and vegetal hemisphere. The results confirm that both GRGDS and anti-~ Fab' substantially inhibit the binding of '=I-FN t0 blastomeres of the blastocoele roof. As shown in Fig. 3 B, the incorporation of '25I-FN was minimal in the presence of GRGDS or anti-/~, Fab' when compared with control experiments performed with peptide P2 or FalY absorbed with the integrin antigen.
Finally, in fluorescence localization studies with FITC-FN (50/~g/ml), FN did not become organized into fibrils when incubated with either GRGDS (200 pg/ml) or anti-/3, Fab' (250 ftg/ml). Conversely, FN-fibril formation occurred normally in the presence of collagen-binding peptide P2 (200 #g/ml) (data not shown).
Inhibition of Fibronectin-fibril Formation by Intracellular Injection of Antibodies to Cytoplasmic Domain of lntegrin {3t Subunit
Since FN adhesion receptors have been proposed to have transmembrane functions, we examined whether an intracellular perturbation of /~, subunit of integrins might also affect extraceUular matrix assembly. Fig. 2 B) ; ( + + ) FN fibrils all around blastomeres (as in Fig. 2 C) ; ( + + + ) FN fibrils radially arranged on the cell surface (as in Fig. 2 D) ; (+ + + +) extensive, anastomosed FN fibrils (as in Fig. 2 E) .
Monovalent antibodies were injected into fertilized eggs before the first cleavage. The results of intracytoplasmic injections performed with antibodies against the cytoplasmic domain of integrin 13, subunit are summarized in Table I .
The main conclusion is that these monovalent antibodies cause dose-dependent and reversible defects in FN-fibril formation. There is a slight inhibition of FN-fibril formation at 10 ng of Fab'/embryo. This inhibition is characterized by a delay in the appearance of the first fibrils. Based on a sample of 10 embryos, this delay is estimated to be 7-8 h. With concentrations ranging from 25 to 50 ng of Fab'/embryo, the delay in FN-fibril formation increased to 17-24 h. In controls with injection buffer (10% MBS), or nonimmune FalY at 50 ng/embryo, a normal sequence of FN-fibril formation occurred.
An example of the defective extracellular matrix of FN obtained after injection of 50 ng Fab' fragments is presented in Fig. 4 . Observations at early, mid-, or late blastula (stages 5, 6, 7) showed the same results, i.e., no fluorescent fibrils were detected on the inner surface of the blastocoele roof (Fig. 4 A) . It was not until the early gastrula stage (stage 8a) that the first fibrils appeared at the periphery of cells (Fig.  4 B) . Their distribution was identical to that observed in control embryos at the much earlier midblastula stage (stage 6) (compare Figs. 4 B and 2 C) . Later, FN-fibril formation was restored, but with a delay of '~ 24 h in forming patterns that matched those of control embryos (Fig. 4 C) .
Antibodies were also injected at the two-cell stage. Fab' antibodies (25 ng) were introduced into one blastomere in the presence of RLDx. The noninjected blastomere provides an internal control for each injection, and the labeled dextran permits identification of the injected blastomere progeny. blastula stage (stage 6). It was injected at the two-cell stage with RLDx and anti-/~ COOH Fab' (25 ng). The cells divided normally and progeny of the injected blastomere was clearly identifiable. When such embryos reached the late blastula stage (stage 7), the blastocoele roofs were dissected, fixed, and submitted to immunodetection of FN. Rhodaminelabeled cells lacked FN-fibrils on their inner cell surface. In the area of contact between labeled and unlabeled blasto-meres, the surface of rhodamine-labeled cells was devoid of FN fibrils while neighboring unlabeled cells exhibited normal extracellular fibrils (Fig. 5 B) . The same results are obtained at later stages of development. Treated cells lacking FN fibrils were surrounded by extracellular matrix-containing FN.
To assess the specificity of this inhibition of FN-fibril formation, we have performed five types of control experiments: (a) injection of nonimmune IgG of rabbit, mouse or human; (b) RLDx alone; (c) RLDx plus nonimmune Fat/; (d) an absorption experiment with RLDx and Fat/preincubated with amphibian integrin ~ subunit; (e) RLDx plus Fat/mixed with the synthetic peptide used for immunizations. Injections of various nonimmune IgG as well as RLDx alone or Fat/preincubated with purified amphibian integrin B~ subunit had no deleterious effects on fibrillogenesis. Finally, we attempted to block the activity of Fat/by mixing them with the synthetic peptide that was used as antigen; this probe itself produced a marked delay of the cleavage of labeled cells, whereas progeny of uninjected blastomere divided normally.
Experiments performed with exogenous iodinated or fluoresceinated FN confirmed the above findings. First, 100 ng of anti-fl~ COOH Fat/were injected intracellularly into fertilized embryos. When injected embryos reached the early blastula stage (stage 5), a solution of 50/~g/ml (final amount, 10 ng) of iodinated or fluoresceinated FN was injected into the blastocoele. 18 h later, when control embryos reached the early gastrula stage (stage 8a) radioactive binding data and immunofiuorescence observations revealed that exogenous FN was not detectably bound at the inner ectodermal cell surface of treated embryos (not shown).
Development of Embryos IntraceUularly Injected with Antibodies to Cytoplasmic Domain of lntegrin [3~ Subunit
Because injected embryos showed striking defects in FNfibril formation, and because these fibrils provide a substrate for mesodermal cell migration (Boucaut et al., 1984a,b; Darribere et al., 1988) , we also studied the later development of injected living embryos.
Comparisons of the timing of gastrulation in uninjected embryos and in eggs injected with anti-t, Fat/at different concentrations showed that in all cases, the formation of the dorsal lip of the blastopore was unaffected. Nevertheless various degrees of subsequent defects in gastrulation were observed. The results obtained are summarized in Table II . They indicate that there is a variation not only in the percentage of embryos with defects but also in the severity of the gastrulation arrest. The three types of defects described are in agreement with those obtained when antibodies against avian integrins were injected into the blastocoele, i.e., extracellularly (Darribere et al., 1988) . With low antibody concentrations (10 ng/embryo), no significant perturbation of gastrulation could be observed. With 25 ng of antibodies per embryo, which produces a delay of 7-8 h in FN-fibril formation (Fig.  4, A and B) , effects ranging from a slight delay to complete inhibition of gastrulation were obtained (Table II) . More severely affected embryos were obtained in response to injections of 100 ng of antibodies, 83% of the embryos showed complete inhibition of gastrulation (Table II) .
A series of injections were performed to introduce anti- bodies preferentially into lateral blastomeres of developing embryos. The results showed that intracytoplasmic injections of anti-/~ COOH Fat/produced lateral defects of FNfibril formation, which could be well correlated with a delay in mesodermal cell migration. The most obvious and consistent defects were found when neural folds failed to form properly. This was demonstrated by coinjecting 100 ng of antibodies and RLDx into one blastomere at the two-cell stage, in which case one-half of the neurula is derived from the injected cell. The labeled half of the embryo failed to form neural folds whereas the contralateral control was normal (Fig. 6 ).
Discussion
In this report, we provide new evidence that the integrin/~, subunit and the Arg-Gly-Asp recognition signal are essential for FN-fibril formation in vivo. Our major results are: (a) interspecies injection of exogenous FN into the blastocoele of living embryos still permits assembly into extracellular fibrils with the same time-dependent pattern as endogenous FN; (b) fibril formation from exogenous FN is prevented by both RGD-containing peptides and polyclonal Fat/to the whole/3~ subunit of amphibian integrin applied extracellularly; (c) intracytoplasmic injections of antibodies to the carboxy-terminal domain of/~ produce a reversible matrix assembly defect; and (d) defective mesodermal cell migration occurs in areas of embryos devoid of FN-fibrils as a result of antibody injection. Before testing the ability of blastomeres to assemble exogenous FN into fibrils, we reexamined the kinetics of for- mation of the FN-containing extracellular matrix. Careful examination shows a reproducible, progressive, spatiotemporal organization of FN fibrils. In early blastulae (stage 5), they appear first at the periphery of blastomeres. Later on (by stage 7), they also appear over the surface of the central portion of cells. This pattern of formation is consistent with results described for cultured fibroblasts. For example, when fibroblasts were seeded onto FN-substrata, they apparently organized FN into fibrils from the periphery to the center of cells (Avnur and Geiger, 1981; Grinnell, 1986) . This result is also in agreement with our recent observations of FN-fibril formation in Rana pipiens embryos (Johnson et al., 1990) .
When exogenous labeled FNs were injected into the blastocoele at the initiation of FN-fibril formation, we were able to observe matrix assembly. Iodinated and fluoresceinated FNs were incorporated into fibrils in a slow time-dependent manner. The stage-dependent kinetics of FITC-FN assembly into fibrils is comparable with that for endogenous FN-fibril formation. It should be noted that fibril formation from exogenous FN is specific and saturable, because an excess of unlabeled FN prevents matrix assembly of labeled FN. Furthermore, on FN fibrils transferred to slides, no exogenous labeled FN is assembled into fibrils. This last observation suggests that in our experimental system, preexisting FN fibrils do not act as a primer for spontaneous exogenous FN fibrillogenesis and also that a direct cell surface interaction is needed. These results in vivo are generally consistent with those found using fibroblast model systems (McDonald, 1988) , although this system displays a stage-specific regulation of FN assembly. Interestingly, we also find that in living embryos, endodermal blastomeres are unable to organize FN into fibrils even in the presence of excess labeled FN. This result indicates cell-type specificity of matrix assembly.
The experimental system developed here thus provides a useful model for studies of FN-fibril formation in vivo. We have used this in vivo system to evaluate whether the integrin 13, subunit is essential for FN-fibril formation.
We demonstrated that the assembly of exogenous FN by animal blastomeres is prevented both by RGD-containing peptides and by antibodies to the amphibian /3, subunit. The simplest interpretation of these results is that FN-fibril formation in vivo requires the extracellular domain of integrin/~, subunit. Moreover, the sensitivity to inhibition by an RGD-containing peptide suggests that the FN receptor (integrin VLA-5) is the molecule responsible, although the concurrent involvement ofa FN-binding vitronectin receptor cannot be formally excluded. This is, to our knowledge, the first report that FN matrix assembly can be inhibited by RGDcontaining peptides. Previous work with fibroblast model systems in vitro indicates that high levels of the large cell-adhesive domain of FN will partially inhibit assembly (McDonald et al., 1988) , but the sensitivity to inhibition found in the present study was unexpectedly high. In fibroblasts in vitro, the non-cell-adhesive amino-terminal domain appears to play a particularly central role in FN binding to the postulated matrix assembly receptor. It is of interest that in similar experiments with human fibroblasts in vitro that have already initiated matrix assembly, RGD peptides do not cause any inhibition of FN binding to the matrix assembly receptor (Fogerty, E J., and D. E Mosher, personal communication), suggesting that our in vivo system may use somewhat different mechanism. In this amphibian developmental system, the data suggest that the integrin (FN-receptor) ). This binding is inhibited by a peptide corresponding to the cytoplasmic domain of integrin/~ subunit (Buck and Horwitz, 1987) . Another possibility is that antibodies prevent the noncovalent association of ~i~ with the ,~ subunit, which is needed for ligand specificity.
